January 13, 2025 Truveta sells stakes to Regeneron, Illumina in deal to build genetic database Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals , Illumina and 17 ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...